MoneyWorks4Me

Sun Pharmaceutical Industries informs about disclosures

20 Apr 2022 Evaluate

Sun Pharmaceutical Industries has informed that the Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 19, 2022 for Shanghvi Finance.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..